Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 2
1948 6
1949 3
1950 1
1951 5
1952 4
1953 2
1954 5
1955 4
1956 4
1957 6
1958 5
1959 4
1960 10
1961 11
1962 10
1963 11
1964 12
1965 8
1966 3
1967 8
1968 7
1969 13
1970 11
1971 16
1972 18
1973 14
1974 15
1975 14
1976 11
1977 22
1978 15
1979 27
1980 19
1981 30
1982 27
1983 30
1984 33
1985 48
1986 44
1987 62
1988 67
1989 80
1990 71
1991 74
1992 107
1993 116
1994 93
1995 101
1996 92
1997 81
1998 117
1999 92
2000 120
2001 94
2002 113
2003 115
2004 140
2005 139
2006 181
2007 176
2008 176
2009 157
2010 202
2011 181
2012 222
2013 212
2014 262
2015 244
2016 284
2017 304
2018 340
2019 314
2020 403
2021 500
2022 494
2023 494
2024 528
2025 518

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,768 results

Results by year

Filters applied: . Clear all
Page 1
2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease.
Hoang TD, Stocker DJ, Chou EL, Burch HB. Hoang TD, et al. Endocrinol Metab Clin North Am. 2022 Jun;51(2):287-304. doi: 10.1016/j.ecl.2021.12.004. Epub 2022 May 11. Endocrinol Metab Clin North Am. 2022. PMID: 35662442 Free PMC article. Review.
The management of hyperthyroidism and extrathyroidal manifestations of Graves disease remains complex. Considerations that include patient preference, age, comorbidity, pregnancy, tobacco smoking, and social determinants of health must all be weaved into a cohesive …
The management of hyperthyroidism and extrathyroidal manifestations of Graves disease remains complex. Considerations that inc …
Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association.
Burch HB, Perros P, Bednarczuk T, Cooper DS, Dolman PJ, Leung AM, Mombaerts I, Salvi M, Stan MN. Burch HB, et al. Thyroid. 2022 Dec;32(12):1439-1470. doi: 10.1089/thy.2022.0251. Epub 2022 Dec 8. Thyroid. 2022. PMID: 36480280 Free PMC article.
Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for h …
Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emer …
Thyroid eye disease: a review.
Weiler DL. Weiler DL. Clin Exp Optom. 2017 Jan;100(1):20-25. doi: 10.1111/cxo.12472. Epub 2016 Oct 4. Clin Exp Optom. 2017. PMID: 27701774 Free article. Review.
Thyroid eye disease is a multifactorial autoimmune disease with a spectrum of signs and symptoms. Oftentimes, the diagnosis of thyroid eye disease is straightforward, based upon history and physical examination. The purpose of this …
Thyroid eye disease is a multifactorial autoimmune disease with a spectrum of signs and symptoms. Oftentimes, th …
Future Projections in Thyroid Eye Disease.
Barbesino G, Salvi M, Freitag SK. Barbesino G, et al. J Clin Endocrinol Metab. 2022 Aug 8;107(Suppl_1):S47-S56. doi: 10.1210/clinem/dgac252. J Clin Endocrinol Metab. 2022. PMID: 36346684 Free PMC article. Review.
BACKGROUND AND AIMS: This review aims to summarize current and emerging therapies for treatment of thyroid eye disease (TED), in the light of novel understanding of pathogenetic mechanisms, leading to new treatment options and clinical trials. ...Searches wer …
BACKGROUND AND AIMS: This review aims to summarize current and emerging therapies for treatment of thyroid eye disease …
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management.
Wiersinga WM, Eckstein AK, Žarković M. Wiersinga WM, et al. Lancet Diabetes Endocrinol. 2025 Jul;13(7):600-614. doi: 10.1016/S2213-8587(25)00066-X. Epub 2025 May 2. Lancet Diabetes Endocrinol. 2025. PMID: 40324443 Review.
Thyroid eye disease (TED; also known as Graves' orbitopathy), causes swollen extraocular muscles and orbital fat. ...Investigation of TED involves assessment of disease activity (inflammation) and disease severity. TED is predominantly mi …
Thyroid eye disease (TED; also known as Graves' orbitopathy), causes swollen extraocular muscles and orbital fat …
Thyroid eye disease: Redefining its management-A review.
Jain AP, Jaru-Ampornpan P, Douglas RS. Jain AP, et al. Clin Exp Ophthalmol. 2021 Mar;49(2):203-211. doi: 10.1111/ceo.13899. Epub 2021 Jan 22. Clin Exp Ophthalmol. 2021. PMID: 33484076 Review.
Thyroid eye disease (TED) is a debilitating, vision threatening disease that dramatically alters patients' quality of life. Until recently, the management of TED is a long arduous course with supportive therapy, followed by an extensive surgical treatm …
Thyroid eye disease (TED) is a debilitating, vision threatening disease that dramatically alters patients' quali …
Thyroid eye disease: current and potential medical management.
Pouso-Diz JM, Abalo-Lojo JM, Gonzalez F. Pouso-Diz JM, et al. Int Ophthalmol. 2020 Apr;40(4):1035-1048. doi: 10.1007/s10792-019-01258-7. Epub 2020 Jan 9. Int Ophthalmol. 2020. PMID: 31919775 Review.
INTRODUCTION: Thyroid eye disease (TED) is the most frequent extra-thyroid manifestation of Graves' disease and it is more frequent in middle age and in female gender. Nowadays, the causal mechanisms of this disease are not complet …
INTRODUCTION: Thyroid eye disease (TED) is the most frequent extra-thyroid manifestation of Graves' di …
Thyroid Eye Disease and Myasthenia Gravis.
Bojikian KD, Francis CE. Bojikian KD, et al. Int Ophthalmol Clin. 2019 Summer;59(3):113-124. doi: 10.1097/IIO.0000000000000277. Int Ophthalmol Clin. 2019. PMID: 31233419 Review. No abstract available.
Treatment of Hyperthyroidism in Graves' Disease Complicated by Thyroid Eye Disease.
Bartalena L, Smith TJ. Bartalena L, et al. J Clin Endocrinol Metab. 2025 Mar 17;110(4):922-930. doi: 10.1210/clinem/dgaf009. J Clin Endocrinol Metab. 2025. PMID: 39787151 Review.
Thyroid eye disease (TED) is the most consequential extrathyroidal manifestation or complication of Graves' disease (GD). ...Search Strategies Current guidelines, original articles, clinical trials, systematic reviews, and meta-analyses up to Ju …
Thyroid eye disease (TED) is the most consequential extrathyroidal manifestation or complication of Graves' d …
Thyroid Eye Disease.
Szelog J, Swanson H, Sniegowski MC, Lyon DB. Szelog J, et al. Mo Med. 2022 Jul-Aug;119(4):343-350. Mo Med. 2022. PMID: 36118816 Free PMC article.
Thyroid eye disease, although rare, is the most common inflammatory orbital disorder and is associated with autoimmune thyroid dysfunction. ...We will review the diagnostic criteria, immunologic basis, clinical course, and medical and surgical treatmen …
Thyroid eye disease, although rare, is the most common inflammatory orbital disorder and is associated with autoimmune …
7,768 results